Compare · CJMB vs RELX
CJMB vs RELX
Side-by-side comparison of Callan JMB Inc. (CJMB) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CJMB and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
- RELX carries a market cap of $57.98B.
- Over the past year, CJMB is down 74.8% and RELX is down 31.6% - RELX leads by 43.2 points.
- RELX has been more active in the news (8 items in the past 4 weeks vs 4 for CJMB).
- RELX has more recent analyst coverage (10 ratings vs 0 for CJMB).
- Company
- Callan JMB Inc.
- RELX PLC PLC
- Price
- $1.04-10.30%
- $36.53+1.15%
- Market cap
- -
- $57.98B
- 1M return
- -43.51%
- +12.55%
- 1Y return
- -74.76%
- -31.60%
- Industry
- Real Estate
- Real Estate
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- 2015
- News (4w)
- 4
- 8
- Recent ratings
- 0
- 10
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest CJMB
- Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure
- Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
- Callan JMB Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
- SEC Form 10-K filed by Callan JMB Inc.
- Callan JMB Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update
- Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
- SEC Form 4 filed by Croyle David J
- Callan JMB Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
Latest RELX
- WEPACK 2026 Concludes on a Record High, Reinforcing China's Role at the Heart of the Global Packaging Industry
- SEC Form 6-K filed by RELX PLC PLC
- Cytora and LexisNexis Risk Solutions announce strategic relationship to enhance risk selection and automation for U.S. commercial insurers
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- LexisNexis Risk Solutions Builds on Agenium Alliance with Expanded Medical Data Access for Life Insurers
- Synthetic Identities and Agentic Bots Posing as Human Contribute to 8% Global Rise in Fraud Attacks - LexisNexis Risk Solutions
- RELX upgraded by Citigroup
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC